International Visiting Fellowships
International visiting fellowships make it possible to integrate renowned foreign scientists into the Berlin research landscape to further strengthen the international profile of NeuroCure’s partner universities and research facilities, and to foster collaborative projects.
Visiting fellows come to Berlin to participate actively in the research and teaching activities of the Cluster. This can take the form, for example, of joint projects, the development of new technologies, or scientific lectures as a supplement to teaching.
The Cluster of Excellence supports international visiting fellows through direct funding of NeuroCure Visiting Fellowships, and by hosting fellows from other Berlin programs such as the Einstein Foundation Berlin and Berlin Institute of Health in NeuroCure labs. Some international fellows, following successful collaborations with NeuroCure colleagues, have gone on to receive fellowships from other prestigious institutions such as the Alexander von Humboldt Foundation.
NeuroCure Visiting Fellows
Prof. Dr. Martyn Goulding has been a NeuroCure Visiting Fellow since April 2016. During his visits to Berlin, he works in the laboratory of Prof. Dr. Carmen Birchmeier at the MDC.
Martyn Goulding is Chair of the Molecular Neurobiology Laboratory at the Salk Institute for Biological Studies in La Jolla, Ca. Following PhD studies in molecular cell biology at the University of Auckland in New Zealand, he did postdoctoral work in developmental biology at the Max Planck Institute in Göttingen. He subsequently worked as MRC Senior Research Fellow at the University of London, UK, before moving to California for a professorship/adjunct professorship at the Salk Institute and University of California San Diego, Department of Biology, respectively.
Martyn Goulding’s research focuses on genetically identifying and functionally characterizing interneuron cell types in the spinal cord that make up the spinal sensorimotor circuitry. His lab has made fundamental discoveries regarding the identity and function of the spinal interneurons (INs) that generate and pattern rhythmic locomotor movements. Current research in his lab is directed at dissecting the spinal circuitry in the dorsal horn that transmits and gates pain, itch and innocuous touch.
Prof. Dr. Hans-Georg Kuhn has been a NeuroCure Visiting Fellow since April 2016. During his visits to Berlin, he works in the laboratory of Prof. Dr. Ulrich Dirnagl at the Charité, Department of Neurology.
Georg Kuhn is Professor for Regenerative Neuroscience at the Center for Brain Repair and Rehabilitation, University of Gothenburg, Sweden. Following doctoral studies in molecular neurobiology at the Heinrich Heine University Düsseldorf, he did postdoctoral work at the Department of Neurosciences, University of California San Diego, then the Laboratory of Genetics at the Salk Institute, California. He was subsequently Group Leader of the Neurogenesis lab at the University of Regensburg, and later lecturer at the Institute for Neuroscience and Physiology at the University of Gothenburg.
The goal of Kuhn’s research is to stimulate repair mechanisms in the brain to achieve structural and functional improvements following neurological disease. He focuses on characterizing mechanisms and signaling in the periphery that could stimulate cellular plasticity mechanisms in the CNS. This involves animal models for stroke and radiation damage, as well as cell culture models. Kuhn’s research is also associated with epidemiological investigations into the effect of cardiovascular fitness on cognition and neurological disease, and clinical studies on multi-sensory stimulation in late neurorehabilitation following stroke.
Prof. Dr. Alison Lloyd has been a NeuroCure Visiting Fellow since April 2015. She works in the laboratory of Prof. Dr. Britta Eickholt at the Charité Institute of Biochemistry.
Alison Lloyd is Senior Group Leader and Professor of Cell Biology at the MRC Laboratory for Molecular Cell Biology and UCL Cancer Institute, University College London. Following PhD studies in cell and molecular biology at the Institute for Cancer Research, Chester Beatty Laboratories, London, she worked as a postdoctoral fellow at the Faculté de Médecine in Strasbourg, and thereafter as Manager of Technology Transfer at the Ludwig Institute for Cancer Research, London. Prior to her current position, she was a postdoctoral fellow at the Imperial Cancer Research Fund Laboratories in London.
Alison Lloyd's research focuses on cell biogenesis and tissue regeneration and the role of these processes in cancer, using the mammalian peripheral nervous system (PNS) as a model system. Her work is not only relevant for cancer biology, but also for the tumour predisposition syndrome, Neurofibromatosis Type 1 (NF1).
Dr. Panayiota Poirazi has been a NeuroCure Visiting Fellow since April 2016. During her visits to Berlin, she works in the laboratory of Prof. Dr. Matthew Larkum at the Humboldt-Universität zu Berlin, Department of Biology.
Panayiota Poirazi is currently a Research Director (equivalent to full professor) at the Institute of Molecular Biology & Biotechnology, Foundation for Research & Technology-Hellas (IMBB-FORTH), a Center of Excellence in Greece. Following doctoral studies in biomedical engineering at the University of Southern California, Los Angeles, she did postdoctoral work in bioinformatics at the Biomedical Sciences Research Center “Alexander Fleming”, Institute of Immunology in Greece. Thereafter, she joined IMBB-FORTH as a Marie Curie Postdoctoral Researcher.
Panayiota Poirazi is an internationally recognized computational neuroscientist with extensive expertise on developing computational models of neural cells and circuits that are used to understand information processing and learning and memory mechanisms. Her research places special emphasis on understanding how dendrites contribute to information processing and memory capacity of the neural tissue. Her modelling work has resulted in a number of experimentally testable predictions that have greatly influenced the neuroscience field, leading to high-profile experimental studies that have verified these predictions.
Prof. Dr. Evgeny Rogaev has been a NeuroCure Visiting Fellow since April 2016. During his visits to Berlin, he works in the laboratory of Prof. Dr. Victor Tarabykin at the Charité, Institute of Cell Biology and Neurobiology.
Evgeny Rogaev is Professor of Psychiatry at the University of Massachusetts. Following PhD studies in medical genetics at the Russian Academy of Medical Sciences (RAMS) in Moscow, he worked as head of the Molecular Brain Genetics lab at the National Research Center of Mental Health, RAMS. During this time, he also worked as a Visiting Scientist and Visiting Professor at the Centre for Research in Neurodegenerative Diseases at University of Toronto before moving to the USA for his current position. He has also held the position of head of the Evolutionary Genomics lab at the Vavilov Institute of General Genetics in Moscow.
Evgeny Rogaev has experience in both experimental research and bioinformatics. He is known for his landmark discovery of presenilins, the major genes for Alzheimer’s disease. His laboratory has also established high-throughput genomic technologies, which he applies in different neuroscience fields. His current research focuses on elucidating genetic-epigenetic interactions as a putative mechanism underlying many complex neuropsychiatric disorders, including schizophrenia, affective disorders and dementias.
Prof. Dr. Hermona Soreq has been a NeuroCure Visiting Fellow since April 2015. She works in the laboratory of Prof. Dr. Andreas Meisel at the Charité Institute for Neurology.
Hermona Soreq studied molecular biology at the Weizmann Institute of Science and joined the Hebrew University in 1986. She holds the Slesinger Chair of Molecular Neuroscience and is a founding member of the Hebrew University's Edmond and Lily Safra Center for Brain Science.
Hermona Soreq's research is centered on acetylcholine functioning. She pioneered the application of molecular biology and genomics to the study of cholinergic signaling, with a recent focus on its microRNA regulation, and is interested in the checks and brain-to-body blaances of cholinergic mechanisms in health and disease.